| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - | |
| Dir | 13.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2020 | Conroy Kevin T81 | President And CEO | Sale+OE | 18,115 | $85.11 | $1,541,767.65 | -1.8% | |
| Feb 19, 2020 | Cole G Bradley | General Manager - Diagnostics | Sale+OE | 27,356 | $100.00 | $2,735,600.00 | -72.9% | |
| Feb 19, 2020 | Orville Jacob A76 | General Manager, New Ventures | Sale+OE | 1,153 | $100.68 | $116,084.04 | -31.6% | |
| Jan 16, 2020 | Cole G Bradley | General Manager - Diagnostics | Sell | 10,000 | $90.30 | $903,000.00 | -53.6% | |
| Nov 21, 2019 | Cole G Bradley | General Manager - Diagnostics | Sell | 28,016 | $80.38 | $2,251,926.08 | -47.5% | |
| Nov 8, 2019 | Exact Sciences Corp | 10% Owner, See Footnotes | Buy | 37,643,330 | $0.00 | - | -100.0% | |
| Sep 12, 2019 | Johnson Scott C. | SVP - Research And Development | Sale+OE | 3,527 | $108.63 | $383,138.01 | -22.3% | |
| Jul 31, 2019 | Carey Thomas D. | Director | Sell | 10,000 | $117.65 | $1,176,487.02 | -4.2% | |
| Jul 31, 2019 | Zanotti Katherine S50 | Director | Sell | 1,744 | $117.93 | $205,669.92 | -2.2% | |
| Jul 31, 2019 | Doyle James Edward75 | Director | Sell | 2,808 | $117.93 | $331,147.44 | -7.5% |